LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - CervoMed (NASDAQ: CRVO)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CRVO CervoMed
Winton Matthew / officer: Chief Commercial and Business
10/06/2025
Buy
$8.62
75,000
$647K
75,000